Some barriers to adherence for black African people in London are culturally specific
Combining tenofovir with FTC or 3TC boosts chances of HBV suppression for people co-infected with HIV
Australian researchers project that many HIV-positive people will run out of treatment options
Any reduction in viral load has immunologic benefits for people with HIV who have triple-class treatment failure
Neurocognitive impairment results in poorer adherence to HIV therapy
Adherence to hepatitis C treatment: unravelling the complexities
Out-of-clinic adherence club for delivery of ARVs shows better retention than standard of care
